2013 ESC stable coronary artery disease 指南
EuropeanHeartJournal(2013)34,2949–3003ESCGUIDELINES
doi:10.1093/eurheartj/eht296
2013ESCguidelinesonthemanagementofstablecoronaryarterydisease
TheTaskForceonthemanagementofstablecoronaryarterydiseaseoftheEuropeanSocietyofCardiology
TaskForceMembers:GillesMontalescot*(Chairperson)(France),UdoSechtem*(Chairperson)(Germany),StephanAchenbach(Germany),FelicitaAndreotti(Italy),ChrisArden(UK),AndrzejBudaj(Poland),RaffaeleBugiardini(Italy),FilippoCrea(Italy),ThomasCuisset(France),CarloDiMario(UK),J.RafaelFerreira(Portugal),BernardJ.Gersh(USA),AnselmK.Gitt(Germany),Jean-SebastienHulot(France),NikolausMarx(Germany),LionelH.Opie(SouthAfrica),MatthiasP sterer
(Switzerland),EvaPrescott(Denmark),FrankRuschitzka(Switzerland),ManelSabate
´(Spain),RoxySenior(UK),DavidPaulTaggart(UK),ErnstE.vanderWall(Netherlands),ChristiaanJ.M.Vrints(Belgium).
ESCCommitteeforPracticeGuidelines(CPG):JoseLuisZamorano(Chairperson)(Spain),StephanAchenbach
(Germany),HelmutBaumgartner(Germany),JeroenJ.Bax(Netherlands),He
´ctorBueno(Spain),VeronicaDean(France),ChristiDeaton(UK),CetinErol(Turkey),RobertFagard(Belgium),RobertoFerrari(Italy),DavidHasdai(Israel),ArnoW.Hoes(Netherlands),PaulusKirchhof(Germany/UK),JuhaniKnuuti(Finland),PhilippeKolh(Belgium),PatrizioLancellotti(Belgium),AlesLinhart(CzechRepublic),PetrosNihoyannopoulos(UK),MassimoF.Piepoli(Italy),PiotrPonikowski(Poland),PerAntonSirnes(Norway),JuanLuisTamargo(Spain),MichalTendera(Poland),AdamTorbicki(Poland),WilliamWijns(Belgium),StephanWindecker(Switzerland).
DocumentReviewers:JuhaniKnuuti(CPGReviewCoordinator)(Finland),MarcoValgimigli(ReviewCoordinator)
(Italy),He
´ctorBueno(Spain),MarcJ.Claeys(Belgium),NorbertDonner-Banzhoff(Germany),CetinErol(Turkey),HerbertFrank(Austria),ChristianFunck-Brentano(France),OliverGaemperli(Switzerland),
Jose
´R.Gonzalez-Juanatey(Spain),MichalisHamilos(Greece),DavidHasdai(Israel),SteenHusted(Denmark),StefanK.James(Sweden),KariKervinen(Finland),PhilippeKolh(Belgium),SteenDalbyKristensen(Denmark),PatrizioLancellotti(Belgium),AldoPietroMaggioni(Italy),MassimoF.Piepoli(Italy),AxelR.Pries
(Germany),
*Correspondingauthors.Thetwochairmencontributedequallytothedocuments.Chairman,France:ProfessorGillesMontalescot,InstitutdeCardiologie,Pitie-SalpetriereUniversityHospital,Bureau2-236,47-83Boulevarddel’Hopital,75013Paris,France.Tel:+33142163006,Fax:+33142162931.Email:gilles.montalescot@psl.aphp.fr.Chairman,Germany:ProfessorUdoSechtem,Abteilungfu¨rKardiologie,RobertBoschKrankenhaus,Auerbachstr.110,DE-70376Stuttgart,Germany.Tel:+4971181013456,Fax:+4971181013795,Email:udo.sechtem@rbk.de
Entitieshavingparticipatedinthedevelopmentofthisdocument:
ESCAssociations:AcuteCardiovascularCareAssociation(ACCA),EuropeanAssociationofCardiovascularImaging(EACVI),EuropeanAssociationforCardiovascularPrevention&Rehabilitation(EACPR),EuropeanAssociationofPercutaneousCardiovascularInterventions(EAPCI),HeartFailureAssociation(HFA)
ESCWorkingGroups:CardiovascularPharmacologyandDrugTherapy,CardiovascularSurgery,CoronaryPathophysiologyandMicrocirculation,NuclearCardiologyandCardiacCT,Thrombosis,CardiovascularMagneticResonance
ESCCouncils:CardiologyPractice,PrimaryCardiovascularCare
ThecontentoftheseEuropeanSocietyofCardiology(ESC)Guidelineshasbeenpublishedforpersonalandeducationaluseonly.Nocommercialuseisauthorized.NopartoftheESCGuidelinesmaybetranslatedorreproducedinanyformwithoutwrittenpermissionfromtheESC.PermissioncanbeobtaineduponsubmissionofawrittenrequesttoOxfordUniversityPress,thepublisheroftheEuropeanHeartJournalandthepartyauthorizedtohandlesuchpermissionsonbehalfoftheESC.
Disclaimer.TheESCGuidelinesrepresenttheviewsoftheESCandwerearrivedataftercarefulconsiderationoftheavailableevidenceatthetimetheywerewritten.Healthprofes-sionalsareencouragedtotakethemfullyintoaccountwhenexercisingtheirclinicaljudgement.TheGuidelinesdonot,however,overridetheindividualresponsibilityofhealthprofes-sionalstomakeappropriatedecisionsinthecircumstancesoftheindividualpatients,inconsultationwiththatpatientandwhereappropriateandnecessarythepatient’sguardianorcarer.Itisalsothehealthprofessional’sresponsibilitytoverifytherulesandregulationsapplicabletodrugsanddevicesatthetimeofprescription.
&TheEuropeanSocietyofCardiology2013.Allrightsreserved.Forpermissionspleaseemail:journals.permissions@http://doc.xuehai.net
Downloaded from http://doc.xuehai.net/ by guest on June 10, 2014
2013 年欧洲心脏病学会(ESC)发布了稳定 性冠状动脉疾病(stable coronary artery disease, SCAD) 的管理指南(management guideline) 以(下简称 2013 版指南),这一指...
2013 ESC 稳定性冠状动脉疾病管理指南_临床医学_医药卫生_专业资料。2013 ESC 稳定...stable coronary artery disease 制定者:欧洲心脏病学会(ESC,European Society of...
management of stable coronary artery disease of the European Society of ...2013 Aug 30 2013 ESC 稳定性冠状动脉疾病管理 指南 2013 ESC 稳定性冠状动脉...
·· 137 2013 年欧洲心脏病学会( ESC )发布了稳定性 冠状动脉 ( 冠脉 ) 疾病 (stable coronary artery disease , SCAD )的管理指南,与 2006 年稳定型心...
2013ESC稳定型冠心病诊疗指南_临床医学_医药卫生_专业资料。European Heart Journal...stable coronary artery disease of the European Society of Cardiology Task ...
2013 ESC SCAD指南_文化/宗教_人文社科_专业资料。2013 ESC 稳定性冠状动脉疾病指南 定义和病理生理学 ? 稳定性冠状动脉疾病(stable coronary artery , SCAD)通常...
2013ESC稳定性冠心病指南的更新要 点 稳定性冠心病的...stable coronary artery disease of the European ...冠脉显著病损但不属于高危范畴 仅正常冠状动脉或斑块...
Coronary Artery Disease Dr. Ben He MD/PhD Renji...外周动脉疾病 5 – 7 倍3 3–4倍1 4倍(仅...Symptoms Chronic Stable Angina Treatment Objectives ...
2013 ESC guidelines for SCAD_临床医学_医药卫生_专业资料。European Heart Journal...8.3.2.4 Ongoing studies for management of stable coronary artery disease ...
? 《2013ESC稳定性冠心病管理指南》更新要点 ? 新...或1支/多个 主要冠状动脉狭窄≥70% 导致的由运动...stable coronary artery disease of the European ...
2013年ESC稳定型冠心病指南的总结和拓展稳定型冠心病 ...stable coronary artery disease 温州医学院附属第一...无创检查结果异常,对已知或拟诊冠状动脉疾病的无症状...
我要评论